DK153549C - Analogifremgangsmaade til fremstilling af 3-methyl-4-halogen-5-bromethylaminomethylisoxazoler eller farmakologisk acceptable syreadditionssalte deraf - Google Patents
Analogifremgangsmaade til fremstilling af 3-methyl-4-halogen-5-bromethylaminomethylisoxazoler eller farmakologisk acceptable syreadditionssalte derafInfo
- Publication number
- DK153549C DK153549C DK023187A DK23187A DK153549C DK 153549 C DK153549 C DK 153549C DK 023187 A DK023187 A DK 023187A DK 23187 A DK23187 A DK 23187A DK 153549 C DK153549 C DK 153549C
- Authority
- DK
- Denmark
- Prior art keywords
- bromethylaminomethylisoxazoles
- analogue
- halogen
- methyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU63780 | 1980-03-19 | ||
| HU8080637A HU180567B (en) | 1980-03-19 | 1980-03-19 | Method for producing derivatives of isooxazole |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK23187A DK23187A (da) | 1987-01-16 |
| DK153549B DK153549B (da) | 1988-07-25 |
| DK153549C true DK153549C (da) | 1988-12-05 |
Family
ID=10950573
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK122581A DK151012C (da) | 1980-03-19 | 1981-03-18 | Analogifremgangsmaade til fremstilling af 3-methyl-4-halogen-5-aminooxymethyl-isoxazoler eller et syreadditionssalt deraf |
| DK023187A DK153549C (da) | 1980-03-19 | 1987-01-16 | Analogifremgangsmaade til fremstilling af 3-methyl-4-halogen-5-bromethylaminomethylisoxazoler eller farmakologisk acceptable syreadditionssalte deraf |
| DK023087A DK151959C (da) | 1980-03-19 | 1987-01-16 | Analogifremgangsmaade til fremstilling af 3-methyl-4-halogenisoxazol-5-yl-methylenoxyguanidin eller farmakologisk acceptable syreadditionssalte deraf |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK122581A DK151012C (da) | 1980-03-19 | 1981-03-18 | Analogifremgangsmaade til fremstilling af 3-methyl-4-halogen-5-aminooxymethyl-isoxazoler eller et syreadditionssalt deraf |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK023087A DK151959C (da) | 1980-03-19 | 1987-01-16 | Analogifremgangsmaade til fremstilling af 3-methyl-4-halogenisoxazol-5-yl-methylenoxyguanidin eller farmakologisk acceptable syreadditionssalte deraf |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS56158774A (da) |
| BE (1) | BE887954A (da) |
| CA (1) | CA1163631A (da) |
| CH (1) | CH646157A5 (da) |
| DE (1) | DE3110817A1 (da) |
| DK (3) | DK151012C (da) |
| ES (3) | ES8302674A1 (da) |
| FI (1) | FI70011C (da) |
| FR (1) | FR2478634A1 (da) |
| GB (1) | GB2075009B (da) |
| HU (1) | HU180567B (da) |
| IT (1) | IT1211010B (da) |
| SE (1) | SE454695B (da) |
| SU (3) | SU1053750A3 (da) |
| YU (1) | YU42560B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6100260A (en) * | 1997-04-21 | 2000-08-08 | Sumitomo Pharmaceutical Company, Limited | Isoxazole derivatives |
| ES2248894T3 (es) * | 1997-04-21 | 2006-03-16 | Dainippon Sumitomo Pharma Co., Ltd. | Derivados de isoxazol. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL302496A (da) * | 1962-12-22 | |||
| US3808221A (en) * | 1971-04-14 | 1974-04-30 | Hoffmann La Roche | Antiandrogenic n-(3,5-dilower alkyl-4-heterocyclic)methyl)phthalimides |
-
1980
- 1980-03-19 HU HU8080637A patent/HU180567B/hu not_active IP Right Cessation
-
1981
- 1981-03-16 BE BE1/10179A patent/BE887954A/fr not_active IP Right Cessation
- 1981-03-17 YU YU689/81A patent/YU42560B/xx unknown
- 1981-03-17 SE SE8101703A patent/SE454695B/sv not_active IP Right Cessation
- 1981-03-18 FR FR8105378A patent/FR2478634A1/fr active Granted
- 1981-03-18 IT IT8120395A patent/IT1211010B/it active
- 1981-03-18 CH CH182981A patent/CH646157A5/de not_active IP Right Cessation
- 1981-03-18 GB GB8108545A patent/GB2075009B/en not_active Expired
- 1981-03-18 ES ES501095A patent/ES8302674A1/es not_active Expired
- 1981-03-18 DK DK122581A patent/DK151012C/da not_active IP Right Cessation
- 1981-03-18 FI FI810838A patent/FI70011C/fi not_active IP Right Cessation
- 1981-03-19 JP JP4023281A patent/JPS56158774A/ja active Pending
- 1981-03-19 CA CA000373380A patent/CA1163631A/en not_active Expired
- 1981-03-19 SU SU813261940A patent/SU1053750A3/ru active
- 1981-03-19 DE DE19813110817 patent/DE3110817A1/de not_active Withdrawn
-
1982
- 1982-04-01 SU SU823416146A patent/SU1158044A3/ru active
- 1982-04-01 SU SU823414099A patent/SU1152518A3/ru active
- 1982-04-16 ES ES511895A patent/ES8305340A1/es not_active Expired
- 1982-04-16 ES ES511894A patent/ES511894A0/es active Granted
-
1987
- 1987-01-16 DK DK023187A patent/DK153549C/da not_active IP Right Cessation
- 1987-01-16 DK DK023087A patent/DK151959C/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK151959C (da) | 1988-07-11 |
| DK153549B (da) | 1988-07-25 |
| DK23187A (da) | 1987-01-16 |
| ES8401758A1 (es) | 1984-01-01 |
| JPS56158774A (en) | 1981-12-07 |
| YU68981A (en) | 1983-10-31 |
| SE454695B (sv) | 1988-05-24 |
| DK151012C (da) | 1988-07-04 |
| ES501095A0 (es) | 1983-02-16 |
| GB2075009A (en) | 1981-11-11 |
| DE3110817A1 (de) | 1982-03-04 |
| DK23087A (da) | 1987-01-16 |
| FR2478634A1 (fr) | 1981-09-25 |
| ES8302674A1 (es) | 1983-02-16 |
| DK151012B (da) | 1987-10-12 |
| FI70011C (fi) | 1986-09-12 |
| ES511895A0 (es) | 1983-05-01 |
| CA1163631A (en) | 1984-03-13 |
| HU180567B (en) | 1983-03-28 |
| YU42560B (en) | 1988-10-31 |
| GB2075009B (en) | 1983-11-30 |
| FI70011B (fi) | 1986-01-31 |
| IT8120395A0 (it) | 1981-03-18 |
| DK151959B (da) | 1988-01-18 |
| IT1211010B (it) | 1989-09-29 |
| CH646157A5 (en) | 1984-11-15 |
| FI810838L (fi) | 1981-09-20 |
| FR2478634B1 (da) | 1983-11-10 |
| SU1158044A3 (ru) | 1985-05-23 |
| SE8101703L (sv) | 1981-09-20 |
| ES8305340A1 (es) | 1983-05-01 |
| ES511894A0 (es) | 1984-01-01 |
| SU1152518A3 (ru) | 1985-04-23 |
| SU1053750A3 (ru) | 1983-11-07 |
| BE887954A (fr) | 1981-09-16 |
| DK122581A (da) | 1981-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK462380A (da) | Analogifremgangsmaade til fremstilling af 2,4-diaminoquinazolin-forbindelser eller syreadditionssalte deraf | |
| DK150512C (da) | Analogifremgangsmaade til fremstilling af 3-quino-lincarboxylsyrederivater eller syreadditionssalte deraf | |
| DK147362C (da) | Analogifremgangsmaade til fremstilling af ergolen- eller ergolin-derivater eller syreadditionssalte deraf | |
| DK151623C (da) | Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK149111C (da) | Analogifremgangsmaade til fremstilling af histidinderivater eller syreadditionssalte deraf | |
| DK152430C (da) | Analogifremgangsmaade til fremstilling af heterocyclisk substituerede 4-amino-6,7-dimethoxy-2-piperazinoquinazolin-derivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK148795C (da) | Anologifremgangsmaade til fremstilling af 3-(2-morpholino-ethyl-amino)-5-phenyl-pyridazin eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK147858C (da) | Analogifremgangsmaade til fremstilling af 5'-deoxy-5-fluorcytidin eller 5'-deoxy-5-fluoruridin eller fysiologisk tolerable syreadditionssalte dera | |
| DK149630C (da) | Analogifremgangsmaade til fremstilling af tripeptidamider eller -estere eller fysiologisk acceptable syreadditionssalte deraf | |
| DK157862C (da) | Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK151017C (da) | Analogifremgangsmaade til fremstilling af substituerede n-(4-indolyl-piperidino-alkyl)-benzimidazoloner eller fysiologisk acceptable syreadditionssalte deraf | |
| DK148596C (da) | Analogifremgangsmaade til fremstilling af 3-aminosubstituerede pyridaziner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK158983C (da) | Analogifremgangsmaade til fremstilling af benzoylpiperazinestre eller syreadditionssalte deraf | |
| DK146281C (da) | Analogifremgangsmaade til fremstilling af 2-brom-6-fluor-n-2-imidazolidinyliden-benzamin eller syreadditionssalte heraf | |
| DK150597C (da) | Analogifremgangsmaade til fremstilling af 3,4-bis-substituerede 1,2,5-oxadiazol-2-oxider eller farmakologisk acceptable syreadditionssalte deraf | |
| DK146066C (da) | Analogifremgangsmaade til fremstilling af substituerede 2-phenylimino- imidazolidiner eller syreadditionssalte deraf | |
| DK164551C (da) | Analogifremgangsmaade til fremstilling af cyclohexylthienyleddikesyreamider eller fysiologisk taalelige syreadditionssalte deraf | |
| DK149841C (da) | Analogifremgangsmaade til fremstilling af alfa-fluor-methyl-alfa-aminoalkansyrer eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK160498C (da) | Analogifremgangsmaade til fremstilling af 3-methyl-flavon-8-carboxylsyreestere eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK148281C (da) | Analogifremgangsmaade til fremstilling af 8a-substituerede 8,8a-desoxy-8,8a-dihydrooleandomycin-forbindelser eller farmaceutiskacceptable syreadditionssalte deraf | |
| DK148903C (da) | Analogifremgangsmaade til fremstilling af enkephalin-analoge pentapeptidderivater eller syreadditionssalte deraf | |
| DK157135C (da) | Analogifremgangsmaade til fremstilling af 1,2,4-triazol-forbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK144793C (da) | Analogifremgangsmaade til fremstilling af dihydro- eller tetrahydroiminothiaziner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK157023C (da) | Analogifremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK160875C (da) | Analogifremgangsmaade til fremstilling af 3,7-diazabicyklooe3.3.1aa-nonanforbindelser eller farmaceutisk acceptable syreadditionssalte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |